Adapalene/Clindamycin Hydrochloride

阿达帕林/盐酸克林霉素

Report date: 2024/02/23 17:17:10

Base Information

Drug NameAdapalene/Clindamycin Hydrochloride
Drug Alias Name盐酸克林霉素和阿达帕林Clindamycin Hydrochloride and AdapaleneClindamycin Hydrochloride•Adapalene盐酸克林霉素•阿达帕林Clindamycin Hydrochloride-Adapalene +[12] 
ClassificationSmall molecules
Mechanisms of Action50S ribosomal subunit inhibitorsRetinoic acid receptor gamma agonistsRetinoic acid receptor beta agonists
Targets50S ribosomal subunitRetinoic acid receptor gammaRetinoic acid receptor beta
Therapy Area/IndicationsAcne Vulgaris
Global Approved IndicationsAcne Vulgaris
Approved Indications in ChinaAcne Vulgaris
Original Approved Country/TerritoryMainland China
Original Approved Date2024/02/20
Country/TerritoryMainland China
CombinationsYes Clindamycin HydrochlorideAdapalene
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLee'S Pharmaceutical (Hk) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhaoke (Guangzhou) Ophthalmology Pharmaceutical Co Ltd
Inactive CompaniesLee'S Pharmaceutical LtdZhaoke Pharmaceutical (Hefei) Co Ltd
Active IndicationsAcne Vulgaris
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A